Stalder A K, Carson M J, Pagenstecher A, Asensio V C, Kincaid C, Benedict M, Powell H C, Masliah E, Campbell I L
Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California 92037, USA.
Am J Pathol. 1998 Sep;153(3):767-83. doi: 10.1016/S0002-9440(10)65620-9.
To examine the role of tumor necrosis factor (TNF)-alpha in the pathogenesis of degenerative disorders of the central nervous system (CNS), transgenic mice were developed in which expression of murine TNF-alpha was targeted to astrocytes using a glial fibrillary acidic protein (GFAP)-TNF-alpha fusion gene. In two independent GFAP-TNFalpha transgenic lines (termed GT-8 or GT-2) adult (>4 months of age) animals developed a progressive ataxia (GT-8) or total paralysis affecting the lower body (GT-2). Symptomatic mice had prominent meningoencephalitis (GT-8) or encephalomyelitis (GT-2) in which large numbers of B cells and CD4+ and CD8+ T cells accumulated at predominantly perivascular sites. The majority of these lymphocytes displayed a memory cell phenotype (CD44high, CD62Llow, CD25-) and expressed an early activation marker (CD69). Parenchymal lesions contained mostly CD45+ high, MHC class II+, and Mac-1+ cells of the macrophage microglial lineage with lower numbers of neutrophils and few CD4+ and CD8+ T cells. Cerebral expression of the cellular adhesion molecules ICAM-1, VCAM-1, and MAdCAM as well as a number of alpha- and beta-chemokines was induced or upregulated and preceded the development of inflammation, suggesting an important signaling role for these molecules in the CNS leukocyte migration. Degenerative changes in the CNS of the GFAP-TNFalpha mice paralleled the development of the inflammatory lesions and included primary and secondary demyelination and neurodegeneration. Disease exacerbation with more extensive inflammatory lesions that contained activated cells of the macrophage/microglial lineage occurred in GFAP-TNFalpha mice with severe combined immune deficiency. Thus, persistent astrocyte expression of murine TNF-alpha in the CNS induces a late-onset chronic inflammatory encephalopathy in which macrophage/microglial cells but not lymphocytes play a central role in mediating injury.
为研究肿瘤坏死因子(TNF)-α在中枢神经系统(CNS)退行性疾病发病机制中的作用,构建了转基因小鼠,利用胶质纤维酸性蛋白(GFAP)-TNF-α融合基因将小鼠TNF-α的表达靶向星形胶质细胞。在两个独立的GFAP-TNFα转基因品系(称为GT-8或GT-2)中,成年(>4月龄)动物出现进行性共济失调(GT-8)或影响下半身的完全麻痹(GT-2)。出现症状的小鼠有明显的脑膜脑炎(GT-8)或脑脊髓炎(GT-2),大量B细胞以及CD4⁺和CD8⁺ T细胞主要在血管周围部位积聚。这些淋巴细胞大多数表现出记忆细胞表型(CD44高、CD62L低、CD25⁻)并表达早期激活标志物(CD69)。实质病变主要包含巨噬细胞小胶质细胞系的CD45⁺高、MHC II类⁺和Mac-1⁺细胞,中性粒细胞数量较少,CD4⁺和CD8⁺ T细胞也很少。细胞黏附分子ICAM-1、VCAM-1和MAdCAM以及多种α和β趋化因子的脑内表达被诱导或上调,并先于炎症的发生,提示这些分子在CNS白细胞迁移中起重要的信号作用。GFAP-TNFα小鼠CNS中的退行性变化与炎性病变的发展平行,包括原发性和继发性脱髓鞘以及神经变性。在严重联合免疫缺陷的GFAP-TNFα小鼠中出现了疾病加重,伴有更广泛的炎性病变,其中包含巨噬细胞/小胶质细胞系的活化细胞。因此,CNS中鼠TNF-α在星形胶质细胞中的持续表达诱导了迟发性慢性炎性脑病,其中巨噬细胞/小胶质细胞而非淋巴细胞在介导损伤中起核心作用。